Differing flow patterns between ischemically challenged flap skin and flap skeletal muscle: implications for salvage regimens.
In this study, the authors tested the hypothesis that there is a significant difference in spatial patterns of reflow in skin as opposed to skeletal muscle after an ischemic insult. The authors believe that this pathophysiologic difference between the two flap types has significant implications for flap salvage strategies. Bilateral buttock skin flaps (10 x 18 cm) and latissimus dorsi myocutaneous flaps (10 x 20 cm) were elevated in Landrace pigs (n = 7). Flaps on one side of the animal were randomly assigned to 6 hours of arterial occlusion, with the contralateral side acting as control. At 15 minutes, 1 hour, and 4 hours after reflow, radioactive microspheres (15 microm) were injected into the left ventricle. After 18 hours of reperfusion, skin and muscle viability were estimated by intravenous fluorescein and soaking in nitroblue tetrazolium, respectively. Flow rates in the skin with an ischemia-reperfusion injury were significantly reduced (30 to 53 percent), at all time intervals, compared with controls. The flow rate in the fluorescent skin with ischemia-reperfusion injury of the latissimus dorsi flaps (0.037 ml/min/g at 15 min) was greater than in that of the buttock flaps (0.018 ml/min/g). The muscle flaps with ischemia-reperfusion injury had significantly higher flow rates than control muscle flaps at all time intervals studied (at 1 hour, 0.32 ml/min/g compared with 0.16 ml/min/g, respectively). In flap skeletal muscle, an early hyperemic phase during reperfusion maintains a significant blood flow to all regions, including the area of the flap that is destined for necrosis. In flap skin, however, there is a marked decrease in flow rates. These differences have important implications for the intravascular delivery of therapeutic agents to the damaged portions of the flap. Transdermal drug delivery systems should be explored as an alternative to intravascular regimens for the salvage of flap skin with ischemia-reperfusion injury.
Khiabani
Kayvan T
KT
Microsurgical Research Laboratories, the Royal Victoria Hospital, McGill University, Montreal, Canada.
Kerrigan
Carolyn L
CL
D000818:Animals; D001783:Blood Flow Velocity; D002081:Buttocks; D004396:Coloring Agents; D005260:Female; D019793:Fluorescein; D006085:Graft Survival; D008863:Microspheres; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000473:pathology / Q000637:transplantation; D009336:Necrosis; D011868:Radioisotopes; D012039:Regional Blood Flow; D015427:Reperfusion Injury / Q000503:physiopathology*; D012867:Skin / Q000098:blood supply* / Q000473:pathology; D016038:Skin Transplantation; D013524:Surgical Flaps / Q000098:blood supply*; D013552:Swine
D004396:Coloring Agents; D011868:Radioisotopes; D019793:Fluorescein